Internetske stranice TED-a spremne su za e-obrasce od danas, 2. 11. 2022. Pretraživanje se promijenilo: prilagodite unaprijed definirane stručne upite. Upoznajte se s promjenama u rubrici Novosti o stranici i na ažuriranim stranicama za pomoć
Solidarnost EU-a s Ukrajinom
Prozorro+: ukrajinska platforma za javnu nabavu
Belgium-Brussels: Feasibility Study, Design and Prototype Development for a Mapping Platform on COVID-19 Therapeutics in the EU
Section I: Contracting authority
Section II: Object
Feasibility Study, Design and Prototype Development for a Mapping Platform on COVID-19 Therapeutics in the EU
Service contract encompassing the feasibility assessment, the design and prototype development of an interactive platform mapping the production capacity and supply of COVID-19 therapeutics in the EU including products in research and development phases. Such therapeutics can include ICU medicines, heparin, dexamethasone and antibiotics, in vitro diagnostics devices/companion diagnostics.
Please consult the procurement documents available at the address indicated in section I.3).
Feasibility study, design and prototype development for a mapping platform on COVID-19 therapeutics in the EU.
Section III: Legal, economic, financial and technical information
Section IV: Procedure
COV2, Place Charles Rogier 16, B-1210 Brussels, Belgium.
The opening will be held as an online meeting.
Section VI: Complementary information
Please consult the procurement documents available at the address indicated in section I.3). In case of unavailability or disruptions in the functioning of the electronic means of communication provided in section I.3) in the last 5 calendar days before the time limit for receipt indicated in section IV.2.2), the contracting authority reserves the right to extend this time limit and publish the extension at the Internet address provided in section I.3), without a preceding publication of a corrigendum to this notice. Economic operators interested in this procurement are invited to subscribe to the call for tenders at the address in section I.3) in order to get notified when new information or documents are published.